Proposed Rule to Streamline Combo Product cGMPs

Drug GMP Report
Makers of components in co-packaged or single-entity combination products would have two options for showing compliance with cGMPs for drugs or biologics and quality system (QS) requirements for devices under a new proposed rule.

To View This Article:


Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $20.00